48
Participants
Start Date
December 20, 2023
Primary Completion Date
May 13, 2024
Study Completion Date
May 13, 2024
CardioFlux Magnetocardiography
The device is a magnetocardiography (MCG) scanner named CardioFlux, which is paired with a cloud processing software. CardioFlux devices are owned by Genetesis and are currently cleared for the acquisition, display, and analysis of magnetic fields generated by cardiac electrical activity (K182571, FDA clearance letter available for download online)
University of Florida, Gainesville
The Cleveland Clinic Foundation, Cleveland
The Christ Hospital, Cincinnati
Ascension St. John Hospital, Detroit
Lead Sponsor
Genetesis Inc.
INDUSTRY